The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 21, 2023

Filed:

Apr. 02, 2021
Applicant:

The Institute of Cancer Research: Royal Cancer Hospital, London, GB;

Inventors:

Caroline Springer, Sutton, GB;

Richard Marais, Manchester, GB;

Dan Niculescu-Duvaz, Sutton, GB;

Leo Leung, Sutton, GB;

Deborah Smithen, Sutton, GB;

Cedric Callens, Singapore, SG;

Haoran Tang, Manchester, GB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 417/12 (2006.01); A61P 35/00 (2006.01); C07D 263/46 (2006.01); C07D 277/26 (2006.01); C07D 277/36 (2006.01); C07D 333/18 (2006.01); C07D 333/34 (2006.01); C07D 409/12 (2006.01); C12Q 1/37 (2006.01);
U.S. Cl.
CPC ...
C07D 417/12 (2013.01); A61P 35/00 (2018.01); C07D 263/46 (2013.01); C07D 277/26 (2013.01); C07D 277/36 (2013.01); C07D 333/18 (2013.01); C07D 333/34 (2013.01); C07D 409/12 (2013.01); C12Q 1/37 (2013.01); C12Y 304/21 (2013.01);
Abstract

Provided are compounds of the Formula (I), or a pharmaceutically acceptable salt thereof: wherein W, X, Y, Z, x, R, R, R, x and n are defined in the specification. The compounds are inhibitors of lysyl oxidase (LOX) and lysyl oxidase-like (LOXL) family members (LOXL1, LOXL2, LOXL3, LOXL4) and are useful in therapy, particularly in the treatment of cancer. Also disclosed are LOX inhibitors for use in the treatment of a cancer associated with EGFR and biomarkers that predict responsiveness to a LOX inhibitor.


Find Patent Forward Citations

Loading…